Commentary on “Biological Treatment of Vein Grafts and Stents in Lower-Extremity Arterial Reconstruction”

Garcia LA Epidemiology and pathophysiology of lower extremity peripheral arterial disease . J Endovasc Ther. 2006;13(suppl 2): 113-119 .

Selvin E. , Erlinger TP Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000 . Circulation. 2004;110: 738-743 .

Centers for Disease Control and Prevention. Lower extremity disease among persons aged > or = 40 years with and without diabetes—United States, 1999-2002 . MMWR Morb Mortal Wkly Rep. 2005;54: 1158-1160 .

Centers for Disease Control and Prevention. Mobility limitation among persons aged > or = 40 years with and without diagnosed diabetes and lower extremity disease— United States, 1999-2002 . MMWR Morb Mortal Wkly Rep. 2005;54: 1183-1186 .

McDermott MM , Guralnik JM , Ferrucci L. , et al. Functional decline in lower-extremity peripheral arterial disease: Associations with comorbidity, gender, and race . J Vasc Surg. 2005;42: 1131-1137 .

Conte MS , Bandyk DF , Clowes AW , et al. Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery . J Vasc Surg. 2006;43: 742-751 .

Grimm J. , Muller-Hulsbeck S. , Jahnke T. , Hilbert C. , Brossmann J. , Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions . J Vasc Interv Radiol. 2001;12: 935-942 .

Wissgott C. , Scheinert D. , Rademaker J. , Werk M. , Schedel H. , Steinkamp HJ Treatment of long superficial femoral artery occlusions with excimer laser angioplasty: long-term results after 48 months . Acta Radiol. 2004; 45: 23-29 .

Zeller T. , Rastan A. , Schwarzwalder U. , et al. Midterm results after atherectomy-assisted angioplasty of below-knee arteries with use of the Silverhawk device . J Vasc Interv Radiol. 2004;15: 1391-1397 .

Laird JR Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries . J Endovasc Ther. 2006;13(suppl 2): 1130-1140 .

Schillinger M. , Sabeti S. , Loewe C. , et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery . New Engl J Med. 2006; 354: 1879-1888 .

Krankenberg H. , Schlüter M. , Steinkamp HJ , et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST) . Circulation. 2007;116: 285-292 .

Muradin GS , Bosch JL , Stijnen T. , Hunink MG Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis . Radiology. 2001; 221: 137-145 .

Schillinger M. , Exner M. , Mlekusch W. , et al. Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level . Radiology. 2003;227: 419-425 .

Duda SH , Bosiers M. , Lammer J. , et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial . J Vasc Interv Radiol. 2005;16: 331-338 .

Majesky MW Developmental basis of vascular smooth muscle diversity . Arterioscl Thromb Vasc Biol. 2007;27: 1248 .

Scheinert D. , Scheinert S. , Sax J. , et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting . J Am Coll Cardiol. 2005;45: 312-315 .

Caves JM , Chaikof EL The evolving impact of micro-and nanofabrication technologies on stent design . J Vasc Surg. 2006;44: 1363-1368 .